Genomic Health
Illuminating Breast Cancer Recurrence Risk
 |   > Search     |  
Home Genomic Health Contact Us Register Online Portal


How to Order the Test

Submit a Sample

Oncotype DX Results Report

Accreditation


Updated NCCN Guidelines

Online Reporting

Register for Updates

For More Information


Welcome to oncotype DX for Logistics

Welcome to Oncotype DX Logistics

Patient samples for Oncotype DX® are submitted for analysis to the Genomic Health Laboratory, a licensed reference laboratory with a Certificate of Accreditation under the Clinical Laboratory Improvement Amendments (CLIA). Genomic Health is also a CAP (College of American Pathologists) accredited reference laboratory.

Tumor analysis requires formalin-fixed, paraffin-embedded tumor tissue. The results of the Oncotype DX assay are available within 10 to 14 days from the date the tumor sample is sent to Genomic Health.

If you are a treating physician (or other authorized healthcare provider) and would like to order the Oncotype DX Breast Cancer Assay, please select the appropriate links below.

What's New?

June 2, 2008
Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores

May 31, 2008
Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies



Ordering Resources
How to Order the Test
Order Forms
Online Reports
  © 2008 Genomic Health, Inc.  All rights reserved. | Home | Contact Us | Privacy | Terms and Conditions |